Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...

Lung Cancer Screening. Cleveland Clinic. August 16, 2024. CT Scan. Mayo Clinic. May 7, 2024. Slatore C et al. What Is a Lung Nodule? American Thoracic Society. June 2020. What Are Lung Nodules ...

One of the best, however, is at Lao Shan Dong Homemade Noodles in Taipei. Order here. In Sydney, give this hearty dish a whirl at Sunflower Taiwanese Gourmet (147 Broadway).

Aumolertinib blocks EGFR, helping to slow or stop the growth of lung cancer and potentially decreasing tumour size. EGFR is a protein expressed on the surface of cells that helps them grow and divide.

Mark Brooke hopes the program will signal a new era of hope for lung cancer patients. (ABC News: Lucas Hill)The screening program will offer a bulk-billed low-dose CT scan for the 930,000 people ...

A childhood friend of Shan-Le Kearns, recently killed in Ukraine, says he ”was never scared of anything". The 26-year-old died at the start of April while rescuing wounded comrades.

Suanesavanh Vignaket, Minister of Information, Culture and Tourism (MICT), shares Lao PDR’s priorities for sustainable tourism ...

The Ministry of Transport plans to propose the commencement of repairs on the fifth Thai-Lao Friendship Bridge to the Cabinet on June 4. The proposal includes a budget of 50 billion baht aimed at ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer (SCLC). The DLL3xCD3 bispecific has shown that it can help patients live ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard ...